Source: Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Conti, A. Carletti, L. Scuotri, M. Tonelli, M. L. Bartoli, B. Vagaggini, E. Bacci, P. L. Paggiaro (Pisa, Italy). Predictive value of sputum eosinophilia for the rapid decline of FEV1 after a three-day withdrawal of therapy in asthmatic subjects. Eur Respir J 2001; 16: Suppl. 31, 2226

Member's Comments

No comment yet.

Related content which might interest you: Baseline FEV1and sputum neutrophils and macrophages predict the decrease in FEV1 after inhaled corticosteroid withdrawal in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004 Sputum eosinophilia and FEV1 decline in occupational asthma Source: Annual Congress 2008 - Asthma and inhalation injuries at work Year: 2008 Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma Source: International Congress 2018 – Clinical markers of asthma Year: 2018 sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Changes in lung function and airway eosinophilia after reduction of ICS treatment and recurrence of asthmatic symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 547s Year: 2003 FEV1 decline and eosinophilia in occupational asthma Source: Annual Congress 2011 - The work environment in the clinic Year: 2011 Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018 Year: 2019 Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001 A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008 Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry? Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children Year: 2018 Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002 Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Does positive bronchodilator reversibility testing predict positive bronchoprovocative methacholine challenge testing in suspected asthma patients Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Correlation between ECP in induced sputum and asthma symptoms in children treated with budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 450s Year: 2001